ISFR:LSE:LSE-iShares MSCI France UCITS (GBX)

ETF | Others |

Last Closing

USD 5067

Change

+31.00 (+0.62)%

Market Cap

USD 0.16B

Volume

720.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+2.45 (+0.98%)

USD 292,109.69B
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

+224.00 (+1.16%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

-2.75 (-1.41%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.04 (-0.24%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.05 (-0.38%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

-1.80 (-1.51%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.15 (+0.22%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.09 (-0.28%)

USD 260.39B
0QZO:LSE 0QZO

-0.40 (-0.40%)

USD 258.54B

ETFs Containing ISFR:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.83% 88% B+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.83% 88% B+ 82% B
Trailing 12 Months  
Capital Gain 1.99% 36% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.99% 30% F 41% F
Trailing 5 Years  
Capital Gain 114.75% 77% C+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 114.75% 75% C 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 12.19% 68% D+ 71% C-
Dividend Return 12.19% 67% D+ 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.58% 57% F 74% C
Risk Adjusted Return 96.90% 86% B+ 92% A
Market Capitalization 0.16B 56% F 32% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike